Literature DB >> 32051190

Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships.

Esther Molina-Montes1, Lisa Van Hoogstraten2, Paulina Gomez-Rubio2, Matthias Löhr3, Linda Sharp4,5, Xavier Molero6, Mirari Márquez2, Christoph W Michalski7,8, Antoni Farré9, José Perea10,11, Michael O'Rorke12,13, William Greenhalf14, Lucas Ilzarbe15, Adonina Tardon16, Thomas M Gress17, Victor M Barberà18, Tatjana Crnogorac-Jurcevic19, Luis Muñoz-Bellvis20, Enrique Domínguez-Muñoz21, Joaquim Balsells6, Eithne Costello14, Mar Iglesias15, Jorg Kleeff7,8, Bo Kong7, Josefina Mora9, Damian O'Driscoll4, Ignasi Poves15, Aldo Scarpa22, Jingru Yu23, Weimin Ye23, Manuel Hidalgo24,25, Alfredo Carrato26, Rita Lawlor22, Francisco X Real27, Nuria Malats.   

Abstract

BACKGROUND: Despite smoking being a well-established risk factor for pancreatic cancer, there is a need to further characterize pancreatic cancer risk according to lifespan smoking patterns and other smoking features, such as tobacco type. Our aim was to deeply investigate them within a large European case-control study.
METHODS: Tobacco smoking habits and other relevant information were obtained from 2,009 cases and 1,532 controls recruited in the PanGenEU study using standardized tools. Multivariate logistic regression analysis was performed to evaluate pancreatic cancer risk by smoking characteristics and interactions with other pancreatic cancer risk factors. Fractional polynomials and restricted cubic splines were used to test for nonlinearity of the dose-response relationships and to analyze their shape.
RESULTS: Relative to never-smokers, current smokers [OR = 1.72; 95% confidence interval (95% CI), 1.39-2.12], those inhaling into the throat (OR = 1.48; 95% CI, 1.11-1.99) or chest (OR = 1.33; 95% CI, 1.12-1.58), and those using nonfiltered cigarettes (OR = 1.69; 95% CI, 1.10-2.61), were all at an increased pancreatic cancer risk. Pancreatic cancer risk was highest in current black tobacco smokers (OR = 2.09; 95% CI, 1.31-3.41), followed by blond tobacco smokers (OR = 1.43; 95% CI, 1.01-2.04). Childhood exposure to tobacco smoke relative to parental smoking was also associated with increased pancreatic cancer risk (OR = 1.24; 95% CI, 1.03-1.49). Dose-response relationships for smoking duration, intensity, cumulative dose, and smoking cessation were nonlinear and showed different shapes by tobacco type. Effect modification by family history of pancreatic cancer and diabetes was likely.
CONCLUSIONS: This study reveals differences in pancreatic cancer risk by tobacco type and other habit characteristics, as well as nonlinear risk associations. IMPACT: This characterization of smoking-related pancreatic cancer risk profiles may help in defining pancreatic cancer high-risk populations. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32051190     DOI: 10.1158/1055-9965.EPI-19-1027

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  8 in total

1.  Nuclear factor kappa-B contributes to cigarette smoke tolerance in pancreatic ductal adenocarcinoma through cysteine metabolism.

Authors:  Venugopal Gunda; Yashpal S Chhonker; Nagabhishek Sirpu Natesh; Pratima Raut; Sakthivel Muniyan; Todd A Wyatt; Daryl J Murry; Surinder K Batra; Satyanarayana Rachagani
Journal:  Biomed Pharmacother       Date:  2021-10-19       Impact factor: 6.529

Review 2.  Tobacco Smoking and Gastrointestinal Cancer Risk.

Authors:  Hans Scherübl
Journal:  Visc Med       Date:  2022-03-17

3.  The importance of addressing early life environmental exposures in cancer epidemiology.

Authors:  Nicole M Niehoff; Mandy Goldberg; Alexandra J White
Journal:  Curr Epidemiol Rep       Date:  2022-04-05

4.  Association between tobacco substance usage and a missense mutation in the tumor suppressor gene P53 in the Saudi Arabian population.

Authors:  Mikhlid H Almutairi; Bader O Almutairi; Turki M Alrubie; Sultan N Alharbi; Narasimha R Parine; Abdulwahed F Alrefaei; Ibrahim Aldeailej; Abdullah Alamri; Abdelhabib Semlali
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

5.  Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment.

Authors:  ZhiYu Zhao; Wei Liu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

6.  Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features.

Authors:  Silvia Pineda; Evangelina López de Maturana; Katharine Yu; Akshay Ravoor; Inés Wood; Núria Malats; Marina Sirota
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

Review 7.  Recent advances in understanding pancreatic cancer.

Authors:  Martyn C Stott; Lucy Oldfield; Jessica Hale; Eithne Costello; Christopher M Halloran
Journal:  Fac Rev       Date:  2022-04-20

Review 8.  Smoking and Pancreatic Cancer: Smoking Patterns, Tobacco Type, and Dose-Response Relationship.

Authors:  Muhammad Subhan; Nisha Saji Parel; Parimi Vamsi Krishna; Anuradha Gupta; Kamsika Uthayaseelan; Kivonika Uthayaseelan; Monika Kadari
Journal:  Cureus       Date:  2022-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.